Apr 18, 2013, 05.26 PM | Source: CNBC-TV18
Parag Doctor, Head of Trading Strategies at Keynote Capital advised exiting Orchid Chemicals at around Rs 80-85 levels.
Parag Doctor (more)
Head - Trading Strategies, LKP | Capital Expertise: Equity - Fundamental
Doctor told CNBC-TV18, “Technically Orchid Chemicals has been an underperformer and we expect that to continue. There could be a rally maybe into Rs 80-85 zone which is where there is resistance for the stock. So we advise to exit his holding around that level.”
“If the sentiment of the midcap stocks improves he could get that Rs 80-85 kind of level and he should then switch to large cap pharma stocks like Lupin, Sun Pharma or Cipla. The visibility for those stocks would be much better in the longer term,” Doctor added.
"Orchid received the establishment inspection repo
"Orchid received the Establishment inspection repo
Orchid Pharma Ltd has informed BSE that Orchid rec
The company has got an approval for its ANDA (Abbr
The nod from the USFDA for the first-to-file abbre
Orchid Pharma has received final approval from USF
Ashu Madan of Religare Securities suggests exiting
Ashu Madan of Religare Securities is of the view t